ImpediMed L-Dex® technology for breast cancer, CPT code filed with American Medical Assoc.
Queensland-based ImpediMed (ASX: IPD) announced today that an application for a Category 1 Current Procedural Terminology (CPT) Code has been filed with the American Medical Association.
A prominent US based surgeon sponsored the application, which seeks assignment of a dedicated code that can be used by physicians across the US in billing health insurance providers, that use the company’s L-Dex® technology in the prospective management of breast cancer patients at risk of lymphoedema.
ImpediMed CEO Greg Brown said, “we are honoured to have such an accomplished US surgeon sponsor this important milestone in applying for a category one reimbursement code."
ImpediMed plans to drive lymphoedema education and adoption of pre-emptive care for all patients will be greatly enhanced should this code be successful, he said.
In the US, surgeons are the key to facilitating pre-emptive care, their support of a Category 1 code for the L-Dex test, demonstrates a commitment to protecting the quality of life of patients.
The United States CPT coding process is the mechanism by which new technologies are assigned codes, which are used by US public and private health insurance companies to describe the procedures and services offered by clinicians.
The AMA’s CPT Editorial Panel considers and evaluates new coding requests three times each year.
This coding application will be brought in front of the panel during their February 2010 meeting.
ImpediMed is a global leader in developing and distributing medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status.
Investors have saluted the company's progress, pushing the share price up from $0.51 in July, by 47% to the current $0.75.
Register here to be notified of Proactiveinvestors One2One Forums.
Other Australia Market Wrap articles
-
06/09/10 Aussie stocks set for rise
-
03/09/10 Indonesia edges closer toward uranium mining and nuclear power
-
01/09/10 China and the increase in demand for copper
-
30/08/10 China a modern country in the making
-
27/08/10 Tin and copper gain, despite gloom on Wall Street
-
27/08/10 Rare Earth Metals to continue to shine after China reduces export quotas
-
25/08/10 U.S. home sales data disapoints investors
-
24/08/10 Gold price falls as traders wait for US economic data
-
23/08/10 Weak leads from overseas and election uncertainty, to pull local stocks lower
-
23/08/10 Is copper headed for US$10,000 a tonne?
Other Australia Market Wrap news
-
06/09/10 ADX Energy granted trading halt for Lambouka-1 well announcement
-
25/08/10 Allocate Software hires General Manager for Australia and New Zealand
-
23/08/10 Cape Range to acquire interest in a Zimbabwean gold producing company
-
20/08/10 Is silver set to move higher?
-
19/08/10 India to take on mining giants in diamonds
-
17/08/10 Trading on Wall Street flat
-
29/07/10 Uranium regains its glow
-
28/07/10 Uranium price: single largest weekly increase since May 2009
-
21/07/10 Dow Jones closes higher, gold rebounds
-
20/07/10 ZYL to acquire Kangwane Anthracite Coal Project in South Africa